1. Home
  2. AVTX vs AUDC Comparison

AVTX vs AUDC Comparison

Compare AVTX & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • AUDC
  • Stock Information
  • Founded
  • AVTX 2011
  • AUDC 1992
  • Country
  • AVTX United States
  • AUDC Israel
  • Employees
  • AVTX N/A
  • AUDC N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • AVTX Health Care
  • AUDC Utilities
  • Exchange
  • AVTX Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • AVTX 248.3M
  • AUDC 267.0M
  • IPO Year
  • AVTX 2015
  • AUDC 1999
  • Fundamental
  • Price
  • AVTX $17.99
  • AUDC $9.05
  • Analyst Decision
  • AVTX Strong Buy
  • AUDC Buy
  • Analyst Count
  • AVTX 9
  • AUDC 3
  • Target Price
  • AVTX $30.14
  • AUDC $11.67
  • AVG Volume (30 Days)
  • AVTX 417.9K
  • AUDC 80.4K
  • Earning Date
  • AVTX 11-07-2025
  • AUDC 11-04-2025
  • Dividend Yield
  • AVTX N/A
  • AUDC 4.42%
  • EPS Growth
  • AVTX N/A
  • AUDC 3.22
  • EPS
  • AVTX N/A
  • AUDC 0.46
  • Revenue
  • AVTX $441,000.00
  • AUDC $243,249,000.00
  • Revenue This Year
  • AVTX N/A
  • AUDC $2.52
  • Revenue Next Year
  • AVTX N/A
  • AUDC $1.74
  • P/E Ratio
  • AVTX N/A
  • AUDC $19.56
  • Revenue Growth
  • AVTX N/A
  • AUDC N/A
  • 52 Week Low
  • AVTX $3.39
  • AUDC $7.70
  • 52 Week High
  • AVTX $19.41
  • AUDC $12.72
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 69.56
  • AUDC 37.88
  • Support Level
  • AVTX $15.58
  • AUDC $8.83
  • Resistance Level
  • AVTX $19.20
  • AUDC $9.67
  • Average True Range (ATR)
  • AVTX 1.66
  • AUDC 0.25
  • MACD
  • AVTX 0.26
  • AUDC -0.04
  • Stochastic Oscillator
  • AVTX 77.22
  • AUDC 21.15

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: